Found: 1
Select item for more details and to access through your institution.
Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients.
- Published in:
- Urologia Internationalis, 2000, v. 64, n. 1, p. 3, doi. 10.1159/000030473
- By:
- Publication type:
- Article